MYUNGMOON Pharm co.,Ltd (KRX:017180)
South Korea · Delayed Price · Currency is KRW 1,286.00
+90.00 (7.53%)
Sep 1, 2026, 3:30 PM KST
MYUNGMOON Pharm co.,Ltd Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 42,989 | 61,842 | 60,806 | 76,621 | 97,023 | 159,901 | |
Market Cap Growth | -25.32% | 1.70% | -20.64% | -21.03% | -39.32% | -34.94% |
Enterprise Value | 110,884 | 157,281 | 151,088 | 159,448 | 175,770 | 244,712 |
Last Close Price | 1286.00 | 1850.00 | 1819.00 | 2285.00 | 2870.00 | 4730.00 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | 32.63 | - | - | 12.33 | - |
PS Ratio | 0.22 | 0.32 | 0.33 | 0.45 | 0.64 | 1.16 |
PB Ratio | 0.42 | 0.59 | 0.59 | 0.86 | 1.02 | 1.86 |
P/TBV Ratio | 0.44 | 0.63 | 0.63 | 0.92 | 1.09 | 2.00 |
P/FCF Ratio | - | - | - | - | 25.91 | 332.93 |
P/OCF Ratio | - | - | - | - | 17.72 | 187.02 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.55 | 0.81 | 0.81 | 0.94 | 1.16 | 1.78 |
EV/EBITDA Ratio | 20.49 | 14.57 | 25.21 | 31.07 | 16.47 | - |
EV/EBIT Ratio | 72.80 | 23.01 | 78.34 | 165.44 | 27.32 | - |
EV/FCF Ratio | - | - | - | - | 46.95 | 509.51 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.85 | 0.94 | 0.85 | 1.02 | 0.87 | 0.98 |
Debt / EBITDA Ratio | 16.10 | 9.14 | 14.60 | 17.63 | 7.79 | - |
Debt / FCF Ratio | - | - | - | - | 22.21 | 175.17 |
Net Debt / Equity Ratio | 0.61 | 0.89 | 0.80 | 0.89 | 0.77 | 0.86 |
Net Debt / EBITDA Ratio | 11.61 | 8.57 | 13.80 | 15.36 | 6.86 | -43.87 |
Net Debt / FCF Ratio | -6.34 | -10.93 | -39.23 | -9.65 | 19.54 | 153.27 |
Asset Turnover | 0.70 | 0.74 | 0.75 | 0.73 | 0.67 | 0.59 |
Inventory Turnover | 2.18 | 2.49 | 2.60 | 2.67 | 2.88 | 2.70 |
Quick Ratio | 0.66 | 0.55 | 0.51 | 0.42 | 0.39 | 0.36 |
Current Ratio | 1.06 | 0.96 | 0.87 | 0.70 | 0.64 | 0.60 |
Return on Equity (ROE) | -2.48% | 1.37% | -3.95% | -5.30% | 8.81% | -7.70% |
Return on Assets (ROA) | 0.33% | 1.61% | 0.49% | 0.26% | 1.77% | -1.58% |
Return on Invested Capital (ROIC) | 0.84% | 1.91% | 1.09% | 0.57% | 3.92% | -3.50% |
Return on Capital Employed (ROCE) | 0.80% | 3.90% | 1.20% | 0.80% | 5.40% | -5.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -3.88% | 3.06% | -4.99% | -5.91% | 8.11% | -4.29% |
FCF Yield | -23.05% | -13.68% | -3.47% | -10.65% | 3.86% | 0.30% |
Buyback Yield / Dilution | -1.28% | -0.25% | 0.99% | 0.38% | - | -15.48% |